跳转至内容
Merck
  • Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries.

Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries.

Journal of medicinal chemistry (2008-08-01)
Morteza Malakoutikhah, Meritxell Teixidó, Ernest Giralt
摘要

Several peptide families containing N-methylated amino acids were designed and synthesized using solid-phase peptide synthesis (SPPS). The permeability and phospholipophilicity of these compounds were studied by parallel artificial membrane permeability assay (PAMPA) and immobilized artificial membrane chromatography (IAMC) to select the best peptides in terms of length, terminal groups, and amino acid replacement to be used as carriers that pass through a model of the blood-brain barrier (BBB) by passive diffusion. Furthermore, the enzymatic stability of these peptides in human serum and their cell viability by MTT assay were tested. These peptide families showed great stability and nontoxicity. The three peptides that showed the greatest permeability were coupled to levodopa (a nonpassive permeating drug) and assessed. These peptides effectively transferred levodopa through an artificial membrane by means of passive diffusion.

材料
货号
品牌
产品描述

Sigma-Aldrich
左旋多巴, ≥98% (TLC)
Sigma-Aldrich
咖啡因, powder, ReagentPlus®
Sigma-Aldrich
咖啡因, anhydrous, 99%, FCC, FG
Sigma-Aldrich
卡马西平, powder
Sigma-Aldrich
咖啡因, Sigma Reference Standard, vial of 250 mg
Supelco
熔点标准品 235-237°C, analytical standard
Sigma-Aldrich
咖啡因, anhydrous, tested according to Ph. Eur.
Supelco
Mettler-Toledo® 校准物质 ME 18872,咖啡因, traceable to primary standards (LGC)
Supelco
咖啡因标准液 溶液, analytical standard, 1.0 mg/mL in methanol
Sigma-Aldrich
咖啡因, meets USP testing specifications, anhydrous
Sigma-Aldrich
咖啡因, BioXtra
Sigma-Aldrich
卡马西平, meets USP testing specifications